Aeolus Pharmaceuticl Financials
| AOLS Stock | USD 0.0001 0.00 0.00% |
Aeolus |
Understanding current and past Aeolus Pharmaceuticl Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aeolus Pharmaceuticl's financial statements are interrelated, with each one affecting the others. For example, an increase in Aeolus Pharmaceuticl's assets may result in an increase in income on the income statement.
The data published in Aeolus Pharmaceuticl's official financial statements usually reflect Aeolus Pharmaceuticl's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aeolus Pharmaceuticl. For example, before you start analyzing numbers published by Aeolus accountants, it's critical to develop an understanding of what Aeolus Pharmaceuticl's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Aeolus Pharmaceuticl's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aeolus Pharmaceuticl's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aeolus Pharmaceuticl's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aeolus Pharmaceuticl. Please utilize our Beneish M Score to check the likelihood of Aeolus Pharmaceuticl's management manipulating its earnings.
Aeolus Pharmaceuticl Stock Summary
Aeolus Pharmaceuticl competes with Microsoft, Apple, Alphabet, Amazon, and Meta Platforms. Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California. Aeolus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US00765G1094 |
| Business Address | 26361 Crown Valley |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.aeoluspharma.com |
| Phone | 949 481 9825 |
| Currency | USD - US Dollar |
You should never invest in Aeolus Pharmaceuticl without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aeolus Pink Sheet, because this is throwing your money away. Analyzing the key information contained in Aeolus Pharmaceuticl's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Aeolus Pharmaceuticl Key Financial Ratios
Generally speaking, Aeolus Pharmaceuticl's financial ratios allow both analysts and investors to convert raw data from Aeolus Pharmaceuticl's financial statements into concise, actionable information that can be used to evaluate the performance of Aeolus Pharmaceuticl over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Aeolus Pharmaceuticl reports annually and quarterly.Aeolus Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aeolus Pharmaceuticl's current stock value. Our valuation model uses many indicators to compare Aeolus Pharmaceuticl value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aeolus Pharmaceuticl competition to find correlations between indicators driving Aeolus Pharmaceuticl's intrinsic value. More Info.Aeolus Pharmaceuticl is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aeolus Pharmaceuticl by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aeolus Pharmaceuticl's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aeolus Pharmaceuticl's earnings, one of the primary drivers of an investment's value.Aeolus Pharmaceuticl Systematic Risk
Aeolus Pharmaceuticl's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aeolus Pharmaceuticl volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Aeolus Pharmaceuticl correlated with the market. If Beta is less than 0 Aeolus Pharmaceuticl generally moves in the opposite direction as compared to the market. If Aeolus Pharmaceuticl Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aeolus Pharmaceuticl is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aeolus Pharmaceuticl is generally in the same direction as the market. If Beta > 1 Aeolus Pharmaceuticl moves generally in the same direction as, but more than the movement of the benchmark.
About Aeolus Pharmaceuticl Financials
What exactly are Aeolus Pharmaceuticl Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Aeolus Pharmaceuticl's income statement, its balance sheet, and the statement of cash flows. Potential Aeolus Pharmaceuticl investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Aeolus Pharmaceuticl investors may use each financial statement separately, they are all related. The changes in Aeolus Pharmaceuticl's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aeolus Pharmaceuticl's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Aeolus Pharmaceuticl Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Aeolus Pharmaceuticl is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Aeolus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Aeolus Pharmaceuticl's financials are consistent with your investment objective using the following steps:- Review Aeolus Pharmaceuticl's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Aeolus Pharmaceuticl's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Aeolus Pharmaceuticl's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Aeolus Pharmaceuticl's stock is overvalued or undervalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aeolus Pharmaceuticl. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Aeolus Pink Sheet analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |